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Here  we  characterize  the toxicity  of environmentally-relevant  forms  of  engineered  nano-
materials  (ENMs),  which  can  transform  during  wastewater  treatment  and  persist  in
aqueous  efﬂuents  and  biosolids.  In an  aerosol  exposure  scenario,  cytotoxicity  and  geno-
toxicity of  efﬂuents  and  biosolids  from  lab-scale  sequencing  batch  reactors  (SBRs)  to  A549
human  lung  epithelial  cells  were  examined.  The  SBRs  were  dosed  with  nanoAg,  nano  zero-
valent  iron  (NZVI),  nanoTiO2 and  nanoCeO2 at sequentially  increasing  concentrations  from
0.1 to  20  mg/L.  Toxicities  were  compared  to outputs  from  SBRs  dosed  with  ionic/bulk
analogs,  undosed  SBRs,  and  pristine  ENMs.  Pristine  nanoAg  and  NZVI  showed  signiﬁcantastewater treatment
549  lung epithelial cells
ytotoxicity
enotoxicity
cytotoxicity  to A549  cells  in  a dose-dependent  manner  from  1 to 67  g/mL,  while  nanoTiO2
and  nanoCeO2 only  exerted  cytotoxicity  at 67 g/mL.  Only  nanoAg  induced  a  genotoxic
response,  at  9,  33  and  53 g/mL.  However,  no  signiﬁcant  cytotoxic  or genotoxic  effects  of
the SBR  efﬂuents  or biosolids  containing  nanomaterials  were  observed.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the CC  BY  license  (http://creativecommons.org/licenses/by/3.0/).. Introduction
The concern that engineered nanomaterials (ENMs)
ay  have adverse effects on human health is increasing
s application of nanotechnology in consumer products
xpands [1,2]. Humans can be exposed to ENMs in the
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rg/licenses/by/3.0/).workplace and during use of nano-products, and also
through contact with water, soil, or air to which ENMs
may  have been released [3]. Comprehensive risk assess-
ment of ENMs requires characterization of the toxicity of
ENMs  under a wide range of exposure conditions, includ-
ing  environmental routes. Cytotoxicity and genotoxicity of
common  metal and carbon nanomaterials, such as nanoAg,
nanoTiO2, and carbon nanotubes have been widely studied
in  human lung, dermal, and visceral cells [4–7]. How-
ever, in assessing the risks of ENMs released into the
natural environment, available data on the toxicity of
environmentally-relevant forms of ENMs is lacking [8,9].
Extrapolation of toxicity data based on testing of pristine
ENMs may  not be appropriate because ENMs are highly
reactive by nature and can be chemically, physically and
open access article under the CC BY license (http://creativecommons.
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biologically transformed in the environment, potentially
altering their toxicity [10,11].
Wastewater treatment plants (WWTPs) are a critical
route of ENM receipt and release into the natural envi-
ronment [12–14]. The complex wastewater matrix is likely
to  favor transformation of ENMs. A small portion of ENMs
will  remain in the wastewater efﬂuent, while the major-
ity  will associate with the sludge [15,16] and eventually
be disposed of by land-application, landﬁll, or incineration
[12]. During the reuse of treated wastewater and land-
application of waste sludge (biosolids), there is potential
for  humans to be exposed to transformed ENMs, especially
through inhalation of aerosols generated [17,18]. However,
to  the knowledge of the authors, impacts of human expo-
sure  to transformed ENMs following wastewater treatment
have  not previously been reported.
This study examined cytotoxicity and genotoxicity
of efﬂuents and biosolids from lab-scale sequencing
batch reactors (SBRs) receiving ENMs to A549 human
lung epithelial cells. The SBRs were dosed with nanoAg,
nano zero-valent iron (NZVI), nanoTiO2 and nanoCeO2
at sequentially increasing concentrations from 0.1 to
20  mg/L. Toxicities were compared to outputs from SBRs
dosed  with ionic/bulk analogs (Ag+, Fe2+, bulkTiO2 and
bulkCeO2), outputs from undosed SBRs, and pristine
ENMs.
2. Materials and methods
2.1.  Preparation of samples
NanoAg  (52 ± 12 nm,  prepared using citrate reduction
method), NZVI (46 ± 10 nm,  NANOFER 25S, Rajhrad, Czech
Republic), nanoTiO2 (21 ± 12 nm,  anatase nanopowder,
Sigma–Aldrich, Saint Louis, MO), nanoCeO2 (33 ± 12 nm,
Sigma–Aldrich) and their ionic/bulk analogs [Ag+ as AgNO3
(Fisher, Suwanee, GA), Fe2+ as FeSO4 (Fisher), bulkTiO2
(Sigma–Aldrich) and bulkCeO2 (Sigma–Aldrich)] were pre-
pared/purchased and characterized as described in Ma  et al.
[35].  As previously reported (Ma  et al. [35]), lab-scale nitri-
fying  SBRs fed with synthetic wastewater were set up
and  operated at steady state under three conditions in
duplicate: (1) SBRs dosed with nanoAg, NZVI, nanoTiO2,
or  nanoCeO2; (2) SBRs dosed with Ag+, Fe2+, bulkTiO2, or
bulkCeO2; and (3) undosed SBRs. The dosing was initiated
at  0.1 mg/L and sequentially increased to 1, 10 and 20 mg/L.
The  SBRs were actively nitrifying at the time of this study;
further details on SBR performance are reported in Ma  et al.
[35].  Aqueous efﬂuents and biosolids were sampled at the
end  of 20 mg/L dosing. In preparation for toxicity tests,
samples from duplicate SBRs were combined and sterilized
with  concentrations of nanomaterials in SBR efﬂuents and
biosolids  quantiﬁed by inductively coupled plasma mass
spectrometry (ICP-MS), as described in the Supplementary
Information.
2.2. Cell culture and treatmentA549  human lung alveolar epithelial cells were obtained
from ATCC (#CCL-185, Manassas, VA). Cells were cul-
tured  in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM,ts 1 (2014) 871–876
Thermo Scientiﬁc HyClone, Logan, UT) containing 10%
heat  inactivated fetal bovine serum (FBS, Atlanta Biolog-
icals,  Flowery Branch, GA) and 1% penicillin–streptomycin
(Thermo Scientiﬁc HyClone, Logan, UT), and were main-
tained  in a humidiﬁed incubator at 37 ◦C and 5% CO2.
Cells  were seeded at a density of 1 × 104 in 100 L culture
medium in each well of 96-well plates. At 80% con-
ﬂuency, they were treated for 24 h either with pristine
nanomaterials, ionic/bulk analogs, SBR aqueous efﬂuents,
or  SBR biosolids as indicated. The exposure concentra-
tions of the pristine materials (Table S1) varied from
1  to 67 g/mL for the cytotoxicity assay to estimate
IC50 values. Genotoxicity assays were carried out at key
concentration values based on the results of the cyto-
toxicity assays (Table S1). The exposure concentrations
of nanomaterials and ionic/bulk materials in SBR efﬂu-
ents  and biosolids are shown in Table 1. All samples were
diluted  with the culture medium to target concentra-
tions.
2.3. Cytotoxicity assay
Cell  viability was measured using the WST-1 assay
(Roche, Indianapolis, IN) based on quantiﬁcation of mito-
chondrial activity as an indicator of cytotoxicity. In viable
cells,  the tetrazolium salt WST-1 is converted to solu-
ble  formazan dye by mitochondrial succinate-tetrazolium
reductase, which can be quantiﬁed by absorbance. After the
A549  cells were treated with the samples for 24 h, WST-
1  reagent was  added to each well at 1/10 volume of the
medium. The absorbance was quantiﬁed after incubating
at  37 ◦C for 3 h using a Tecan Saﬁre2 Microplate Reader
(Tecan US In., Research Triangle Pa, NC) at 440 nm with
a  reference wavelength of 660 nm.  All treated A549 cells
(a)  were tested in triplicate in three independent exper-
iments with three controls: (b) untreated A549 cells in
culture  medium; (c) samples in culture medium with-
out  A549 cells; and (d) culture medium only. In a single
experiment, cell viability was  calculated as percentage
of the average absorbance derived from triplicate runs
of  treated cells relative to untreated control cells, with
absorbances of corresponding controls subtracted out to
address  possible matrix interferences: fraction cell viabil-
ity  = [(a − c)/(b − d)].
2.4.  Genotoxicity assay
DNA  damage in A549 cells was detected using
immunoﬂuorescent labeling of H2AX foci as described
elsewhere [19]. At sites of DNA double strand breaks, H2AX,
a  minor nucleosomal histone protein, is rapidly phosphory-
lated and forms H2AX [20]. The experimental and imaging
procedures are provided in the Supplementary Informa-
tion. Three independent experiments were conducted with
at  least 200 cells imaged in a single test. Untreated cells and
cells  treated with 100 M H2O2 for 10 min  were included
as negative and positive controls, respectively. Images were
analyzed  using ImageJ 1.47 (http://rsbweb.nih.gov/ij/) with
a macro designed to subtract background and count the
number of foci within the deﬁned nucleus masks.
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Table 1
Concentration of nanomaterials and ionic/bulk materials in SBR efﬂuents and biosolids, and exposure concentration in cytotoxicity and genotoxicity assays.
SBR efﬂuents (g/L) Exposure concentration (g/L)a Biosolids (g/g total solids) Exposure concentration (g/mL)b
NanoAg 28.43 9.48 2332 0.47
Ag+ 43.67 14.56 2212 0.44
NZVI  7.10 2.37 38,327 7.67
Fe2+ 4.70 1.57 48,061 9.61
NanoTiO2 0.95c 0.32 49,201 9.84
BulkTiO2 1.02c 0.34 67,649 13.53
NanoCeO2 0.25 0.08 22,360 4.47
BulkCeO2 0.86 0.29 26,454 5.29
a SBR efﬂuents were diluted approximately 1:3 in the culture medium.
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.5. Statistical analysis
The  data were presented as mean ± standard devi-
tion of three independent experiments. Student’s t
est  or pairwise t test was conducted in R-2.8.1
http://cran.r-project.org/bin/windows/base/old/2.8.1/) to
etermine statistical differences between samples at a sig-
iﬁcance  level of 0.05 (p < 0.05).
.  Results and discussion
.1.  Toxicity of pristine nanomaterials
Based on the WST-1 assay, the viability of cells exposed
o  nanoAg, Ag+, NZVI and Fe2+ for 24 h decreased signif-
cantly (p < 0.05) in a dose-dependent manner (Fig. S1).
he  IC50 values for these materials were estimated to be
3  ± 2, 21 ± 0.1, 38 ± 2 and 55 ± 2 g/mL, respectively. In
articular, the IC50 of Ag+ was signiﬁcantly lower than
hat of nanoAg (p = 5 × 10−4), a result that is in agree-
ent with other studies using A549 cell targets [21,4].
y  contrast, NZVI was more toxic than its ionic analog,
e2+ (p = 6 × 10−4). In another study, the cytotoxicty of
ZVI (synthesized through reduction of FeCl3 by NaBH4
nd coated with Pd) to human bronchial epithelial cells
6HBE14o was not signiﬁcantly different from Fe2+ [22].
ifferences between the studies could relate to differences
n  NZVI coatings (manufacturer in present study reports
iodegradable organic and inorganic stabilizers) or the dif-
erent  cells used in the assays (A549 versus 16HBE14o).
he viability of cells exposed to nanoTiO2, nanoCeO2 and
heir  bulk analogs only decreased at a concentration of
7  g/mL, by 10–20% (Fig. S1, p < 0.05). But in a few
ther studies, no signiﬁcant cytotoxicity of nanoTiO2 and
anoCeO2 to A549 cells was observed, even at concentra-
ions up to 100 g/mL [23,5,24].
Only cells that were exposed to 33 and 53 g/mL
anoAg and 21 g/mL Ag+ showed signiﬁcantly higher
umbers of H2AX foci per cell (Fig. S2A) and greater per-
entages of cells containing H2AX foci (Fig. S2B) (p < 0.05)
elative  to untreated control cells, suggesting genotoxicity
esulting from DNA double strand breaks. The number of
H2AX  foci per cell exposed to 9 g/mL nanoAg was not
igniﬁcantly different from that of the control cells (Fig.
2A,  p = 0.12), but the percentage of cells containing H2AX
oci  was signiﬁcantly higher than for the control cellstion limit of Ti by ICP-MS and not signiﬁcantly different from concentra-
(Fig.  S2B, p = 0.03). Although IC50 concentrations of NZVI
and  Fe2+ (38 and 55 g/mL, respectively), and nanoTiO2,
nanoCeO2 and the bulk analogs at 67 g/mL induced signif-
icant  cytotoxicity to A549 cells, the number of H2AX foci
were  not signiﬁcantly different in cells treated with these
materials (Fig. S2, p > 0.05). To the authors’ knowledge,
genotoxicity of NZVI to human cells has not been inves-
tigated previously. Genotoxicities have been observed in
A549  cells at concentrations of 2.5–15 g/mL of nanoAg
by 32P post-labeling of DNA adducts [4], 10–50 g/mL of
nanoTiO2 by cytokinesis block micronucleus assay [25],
and  0.5–100 g/mL of nanoCeO2 by alkaline comet assay
[23]. However, in this study, the genotoxicity of nanoAg
could be demonstrated, but not nanoTiO2 or nanoCeO2 at
67  g/mL. The distinct outcome of the nanoTiO2 in the
present study could be attributed to the different geno-
toxicity assays employed. With respect to nanoCeO2, the
prior  study [23] utilized lab-synthesized nanoCeO2 with
a  size range of 16–22 nm,  whereas the present study uti-
lized  commercial nanoCeO2 with an average particle size
of  33 ± 12 nm.
3.2.  Toxicity of SBR efﬂuents and biosolids
Based on a previous study (Ma  et al. [35]), >99% of
nanomaterials and ionic/bulk analogs dosed into the SBRs
partitioned into the sludge relative to the inﬂuent concen-
trations. Concentrations of nanomaterials in SBR aqueous
efﬂuents and biosolids, as well as exposed to A549 cells,
are  shown in Table 1. No signiﬁcant decrease of cell via-
bility  or induction of H2AX foci were observed in A549
cells  exposed to SBR efﬂuents (Fig. 1A and 2, p > 0.05). The
exposure concentration of nanoAg in this study (9.48 g/L)
was  much higher than predicted concentrations in WWTP
efﬂuents (<0.5 g/L) [12–14], while the exposure concen-
trations of NZVI (2.37 g/L), nanoTiO2 (0.32 g/L), and
nanoCeO2 (0.08 g/L) were within or lower than the lower
bound concentrations predicted (0.7–20 g/L for NZVI
[14], 1–70 g/L for nanoTiO2 [12–14], and 0.5 × 10−4 to
2 g/L for nanoCeO2 [13,14]. Results of this study indi-
cated limited toxicity of nanoAg in wastewater efﬂuents
at  higher than environmentally-relevant concentrations to
A549  cells, while the effects of higher concentrations of
NZVI,  nanoTiO2 and nanoCeO2 remain to be determined.
The concentrations of nanomaterials in biosolids in this
study  (>2000 g/g dry mass, Table 1) were signiﬁcantly
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Fig. 1. Characteristic cytotoxicity of A549 cells exposed to (A) wastewater efﬂuents and (B) biosolids from undosed SBR, and SBRs dosed with nanoAg,
Ag+, NZVI, Fe2+, nanoTiO2, bulkTiO2, nanoCeO2, and bulkCeO2 for 24 h by WST-1 assay. Exposure concentrations are shown in Table 1. Error bars represent
standard  deviations of three independent experiments. “*” indicates signiﬁcant decrease of viability compared with untreated control cells (p < 0.05).
Fig. 2. H2AX foci in untreated control A549 cells; cells treated with wastewater efﬂuents from undosed SBR and SBRs dosed with nanoAg, Ag+, NZVI, Fe2+,
ith 100
rcentag
pared nanoTiO2, bulkTiO2, nanoCeO2, and bulkCeO2 for 24 h; and cells treated w
Table  1. Data are presented as (A) number of H2AX foci per cell and (B) pe
of  three independent experiments. “*” indicates signiﬁcant difference com
higher than concentrations predicted in biosolids from
WWTPs (<1000 g/g dry mass) [12–14]. Moreover, 200 g
total  solids/mL represented a high exposure dose relative to
other  studies of effects of aerosolized biosolids to human
lung  cells [26]. The viability of cells exposed to biosolids
at  200 g total solids/mL decreased by 7–10% relative
to untreated control cells (p < 0.05), except for biosolids
containing NZVI (p = 0.08) (Fig. 1B). But, there was  no sig-
niﬁcant  difference between cells exposed to biosolids from
undosed  versus dosed SBRs (p > 0.05), indicating that the
decrease  in cell viability was not likely due to the nanoma-
terials or ionic/bulk materials, but probably instead to the
high  concentration of total solids. Cytotoxicity of biosolids
was  also examined, at 50 and 100 g total solids/mL, and M H2O2 for 10 min. Exposure concentrations of materials are shown in
e of cells containing H2AX foci. Error bars represent standard deviations
with untreated control cells (p < 0.05).
no  signiﬁcant effects were observed relative to control cells
(p  > 0.05, Fig. S3).
Genotoxicity of biosolids was  examined at 200 g
total solids/mL. However, no signiﬁcant differences were
observed in terms of the number of H2AX foci per cell or
in  the percentage of cells containing H2AX foci in cells
treated with biosolids relative to untreated control cells
(Fig.  3, p > 0.05), suggesting little or no DNA damage to
A549  cells at concentrations exceeding most likely aerosol
exposure levels.Uptake  of pristine nanoAg, nanoTiO2, and nanoCeO2
by human cells [21,5,24,27], and NZVI by mammalian
nerve cells [28] has been observed in previous studies, and
the  most commonly identiﬁed mechanism of toxicity was
Y. Ma et al. / Toxicology Reports 1 (2014) 871–876 875
Fig. 3. H2AX foci in untreated control A549 cells; cells treated with biosolids from undosed SBR and SBRs dosed with nanoAg, Ag+, NZVI, Fe2+, nanoTiO2,
b M H2O2
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ata  was  presented as (A) number of H2AX foci per cell and (B) percen
hree  independent experiments. “*” indicates signiﬁcant difference comp
he generation of reactive oxygen species, which induced
xidative stress [27,4,22,25]. Release of Ag+ was consid-
red another potential cause of nanoAg toxicity [29]. Based
n  TEM-EDS mapping carried out in a previous study of
he  SBR biosolids (Ma  et al. [35]), while a large portion of
anoAg  remained dispersed, it mainly formed Ag–S com-
lexes.  Sulﬁdation has been reported to reduce toxicity
f  nanoAg to microbes, aquatic and terrestrial eukaryotic
rganisms due to low solubility of Ag–S complexes [30,31].
imilarly, transformation of nanoAg in this study may  limit
ts  reactivity and result in little toxicity of SBR biosolids to
549  cells. The majority of NZVI, nanoTiO2 and nanoCeO2
ere aggregated, but not chemically modiﬁed. Epithelial
ells are impervious to aggregated nanomaterials by dif-
usion  or macropinocytosis [32]. Therefore, the absence of
ytotoxicity  and genotoxicity of SBR biosolids in this study
ould  be attributed to the inability of aggregated NZVI,
anoTiO2, and nanoCeO2 to enter cells. However, the size
f  the nanomaterial aggregate can affect its physiological
istribution and kinetics, cellular distribution (for example
ithin  the draining lymph node for an aerosolized parti-
le),  cellular uptake, and intracellular processing pathways
33].  Also, it is difﬁcult to ascertain the fate of aerosolized
anomaterials from biosolids in the respiratory tract as
articles  can diffuse and convert during interstitial trans-
ort  depending on their size [34]. Thus, future work may
onsider the toxicity under ex vivo and in vivo conditions.
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